How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia

How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia

Item
http://www.wikidata.org/entity/Q27008173
Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designsTreatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database studyOnce-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia.Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional studyTreatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.Guidelines for the Pharmacotherapy of Schizophrenia in Adults.Once-monthly paliperidone palmitate in early stage schizophrenia - a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia.An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study).Why we need more than just randomized controlled trials to establish the effectiveness of online social networks for health behavior change.
P2860

How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia

Item
http://www.wikidata.org/entity/Q27008173
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
How study designs influence co ...... c treatments for schizophrenia
@ast
How study designs influence co ...... c treatments for schizophrenia
@en
How study designs influence co ...... c treatments for schizophrenia
@nl
type
label
How study designs influence co ...... c treatments for schizophrenia
@ast
How study designs influence co ...... c treatments for schizophrenia
@en
How study designs influence co ...... c treatments for schizophrenia
@nl
prefLabel
How study designs influence co ...... c treatments for schizophrenia
@ast
How study designs influence co ...... c treatments for schizophrenia
@en
How study designs influence co ...... c treatments for schizophrenia
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P3181
P356
P1433
P1476
How study designs influence co ...... c treatments for schizophrenia
@en
P2093
P304
P31
P3181
P356
10.1016/J.SCHRES.2014.04.024
P407
P433
P478
P577
P5875
P698
P921